Cargando…
Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration
BACKGROUND: Blinding trachoma, caused by the bacteria Chlamydia trachomatis, is a neglected tropical disease targeted for elimination by 2020. A major component of the elimination strategy is mass drug administration (MDA) with azithromycin. Currently, program decisions are made based on clinical si...
Autores principales: | Goodhew, Erica Brook, Morgan, Sheri Maria G, Switzer, Andrew J, Munoz, Beatriz, Dize, Laura, Gaydos, Charlotte, Mkocha, Harran, West, Sheila K, Wiegand, Ryan E, Lammie, Patrick J, Martin, Diana L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016634/ https://www.ncbi.nlm.nih.gov/pubmed/24755001 http://dx.doi.org/10.1186/1471-2334-14-216 |
Ejemplares similares
-
Serological Measures of Trachoma Transmission Intensity
por: Martin, Diana L., et al.
Publicado: (2015) -
CT694 and pgp3 as Serological Tools for Monitoring Trachoma Programs
por: Goodhew, E. Brook, et al.
Publicado: (2012) -
The effect of Mass Drug Administration for trachoma on antibodies to Chlamydia trachomatis pgp3 in children
por: West, Sheila K., et al.
Publicado: (2020) -
Longitudinal change in the serology of antibodies to Chlamydia trachomatis pgp3 in children residing in a trachoma area
por: West, Sheila K., et al.
Publicado: (2018) -
Field Evaluation of the Cepheid GeneXpert Chlamydia trachomatis Assay for Detection of Infection in a Trachoma Endemic Community in Tanzania
por: Jenson, Alexander, et al.
Publicado: (2013)